Antipsychotic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application (Schizophrenia, Bipolar Disorder, Unipolar Disorder, Dementia, Others), By Drug Classification(First Generation (Typical), Second Generation (Atypical)) By Company (2022) By Region and Competition

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Antipsychotic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application (Schizophrenia, Bipolar Disorder, Unipolar Disorder, Dementia, Others), By Drug Classification(First Generation (Typical), Second Generation (Atypical)) By Company (2022) By Region and Competition

Forecast Period2024-2028
Market Size (2022)USD 13.03 billion
CAGR (2023-2028)7.37%
Fastest Growing SegmentSchizophrenia
Largest MarketNorth America

MIR Consumer Healthcare

Market Overview

Key Market Drivers

Rising Prevalence of Mental Health Disorders

Advancements in Drug Development


MIR Segment1

Reducing Stigma and Increased Mental Health Awareness

Key Market Challenges

Adverse Side Effects

Treatment Non-Adherence


MIR Regional

Cost of Medications

Key Market Trends

Personalized Medicine Approach

Government Support and Healthcare Policies

Segmental Insights

Application Insights

Drug Classification Insights

Regional Insights

Recent Developments

  • In February 2022, Alkermes plc released positive outcomes fromENLIGHTEN-early, a phase 3b research that assessed the effectiveness of LYBALVIin treating schizophrenia disorder .
  • In February 2021, Dr. Reddy's Laboratories Ltd. introduced tabletscontaining fluphenazine hydrochloride. The drug is used to treat the signs andsymptoms of psychotic illnesses.

Key Market Players

  • Eli Lily and Company
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Otsuka Pharmaceutical Co, Ltd.
  • Pfizer Inc.
  • AbbVie Inc.
  • Dr. Reddy’s Laboratories Limited
  • Otsuka Holdings Co., Ltd.
  • Teva Pharmaceutical Industries Ltd

 By Application

By Drug Classification

By Region

  • Schizophrenia
  • Bipolar Disorder
  • Unipolar Disorder
  • Dementia
  • Others
  • First Generation (Typical)
  • Second Generation (Atypical))
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.